Email updates

Keep up to date with the latest news and content from BMC Neurology and BioMed Central.

Open Access Highly Accessed Pre-publication history

Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators

Samuel Frank

BMC Neurology 2009, 9:62  doi:10.1186/1471-2377-9-62

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 20 Mar 2009
Reviewer's Report Raymund Roos 23 Apr 2009
Resubmission - Version 2 Manuscript Author's comment 14 Jul 2009
Reviewer's Report Raymund Roos 11 Sep 2009
Resubmission - Version 3 Manuscript Author's comment 17 Nov 2009
Editorial acceptance 18 Nov 2009
Published 18 Dec 2009